TrialPanorama/TrialPanorama-database huggingface dataset:
Study 27785095 — Surrogate Endpoint (SUR): Blood pressure
Study 9728898 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 12370851 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 12370851 — Predictive Biomarker (PRD): LCAT mRNA
Genes: LCAT
Study 12370851 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2509069 — Surrogate Endpoint (SUR): Serum creatinine
Study 31898756 — Safety Biomarker (SAF): Hyaluronic acid
Study 26474452 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18785308 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7028935 — Surrogate Endpoint (SUR): Blood pressure
Study 24836310 — Surrogate Endpoint (SUR): Forced vital capacity
Study 18270675 — Surrogate Endpoint (SUR): Blood pressure
Study 3537872 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26797718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 24882370 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 9709470 — Surrogate Endpoint (SUR): Serum creatinine
Study 17764549 — Surrogate Endpoint (SUR): Blood pressure
Study 8138400 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25609853 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25609853 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 17924971 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15207897 — Surrogate Endpoint (SUR): Bone mineral density
Study 9510003 — Predictive Biomarker (PRD): MCAT mRNA
Genes: MCAT; MT
Study 2466454 — Surrogate Endpoint (SUR): Blood pressure
Study 28285280 — Surrogate Endpoint (SUR): Blood pressure
Study 26081658 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24307311 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24307311 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 21876349 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 19236643 — Surrogate Endpoint (SUR): Blood pressure
Study 8239010 — Surrogate Endpoint (SUR): Blood pressure
Study 3010028 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 3010028 — Surrogate Endpoint (SUR): Serum triglycerides
Study 30766555 — Surrogate Endpoint (SUR): Blood pressure
Study 22729798 — Surrogate Endpoint (SUR): Blood pressure
Study 15672306 — Surrogate Endpoint (SUR): Blood pressure
Study 7717488 — Surrogate Endpoint (SUR): Blood pressure
Study 24379596 — Predictive Biomarker (PRD): CBLIF mRNA
Genes: CBLIF; GIF; IFMH
Study 15199619 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 15199619 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 2494014 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 23428878 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23428878 — Safety Biomarker (SAF): IL-6 and IL-10
Study 20840349 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 17320026 — Surrogate Endpoint (SUR): Bone mineral density
Study 15311423 — Surrogate Endpoint (SUR): Blood pressure
Study 3306292 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 31365441 — Surrogate Endpoint (SUR): Blood pressure
Study 19661957 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 19661957 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1346268 — Surrogate Endpoint (SUR): Blood pressure
Study 22264996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22264996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18381581 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20304772 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 22801271 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 25688817 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 25688817 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 24047421 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 20007081 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 2373126 — Surrogate Endpoint (SUR): Blood pressure
Study 28452603 — Surrogate Endpoint (SUR): Blood pressure
Study 24731832 — Surrogate Endpoint (SUR): Blood pressure
Study 17426744 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 17426744 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 17426744 — Predictive Biomarker (PRD): TMPRSS11A mRNA
Genes: TMPRSS11A; ECRG1; HATL1; HESP
Study 17426744 — Predictive Biomarker (PRD): CPSF4 mRNA
Genes: CPSF4; CPSF30; NAR; NEB1
Study 17426744 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study 15837829 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15837829 — Surrogate Endpoint (SUR): Blood pressure
Study 6794419 — Surrogate Endpoint (SUR): Blood pressure
Study 27589225 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 14508230 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 14508230 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 14621737 — Surrogate Endpoint (SUR): Serum creatinine
Study 15981669 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 12589351 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 10475285 — Surrogate Endpoint (SUR): Blood pressure
Study 30659666 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 30659666 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 30659666 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30659666 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 30659666 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 27331913 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 27331913 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 27331913 — Surrogate Endpoint (SUR): Blood pressure
Study 21061756 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 9580313 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 9580313 — Monitoring Biomarker (MOI): HBV DNA
Study 27426936 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 26630576 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26630576 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26630576 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 26630576 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 26630576 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 26630576 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 30222861 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study 30222861 — Surrogate Endpoint (SUR): Blood pressure
Study 2553879 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 2553879 — Predictive Biomarker (PRD): CAMP mRNA
Genes: CAMP; CAP18; FALL39; HSD26
Study 31550354 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19427269 — Pharmacodynamic Biomarker (PDY): Peripheral myelin protein 22
Genes: PMP22; GAS3
Study 11185653 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31535829 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 14523778 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24342681 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 22389919 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20390409 — Surrogate Endpoint (SUR): Bone mineral density
Study 16108943 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24602919 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 16702331 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 11234265 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 20069390 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 15930445 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 1693740 — Surrogate Endpoint (SUR): Blood pressure
Study 25683704 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25683704 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 19522983 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 9172913 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 29614993 — Surrogate Endpoint (SUR): Blood pressure
Study 29614993 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30286768 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 14962813 — Surrogate Endpoint (SUR): Bone mineral density
Study 2928998 — Surrogate Endpoint (SUR): Blood pressure
Study 16204787 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 23975842 — Surrogate Endpoint (SUR): Blood pressure
Study 24408124 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 24408124 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 10381298 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 10381298 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 10193713 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2148504 — Surrogate Endpoint (SUR): Blood pressure
Study 25909149 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25909149 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 20965387 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 17853036 — Surrogate Endpoint (SUR): Blood pressure
Study 16027246 — Surrogate Endpoint (SUR): Blood pressure
Study 16027246 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 10643800 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 8865536 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 8865536 — Surrogate Endpoint (SUR): Serum triglycerides
Study 29652271 — Surrogate Endpoint (SUR): Blood pressure
Study 22728005 — Surrogate Endpoint (SUR): Serum creatinine
Study 12406833 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 31434737 — Predictive Biomarker (PRD): FCGR2C mRNA
Genes: FCGR2C; CD32; FCG2; IGFR2
Study 31434737 — Predictive Biomarker (PRD): FCGR3B mRNA
Genes: FCGR3B; CD16B; FCG3; FCGR3; IGFR3
Study 31434737 — Predictive Biomarker (PRD): FCGR2A mRNA
Genes: FCGR2A; CD32; FCG2; FCGR2A1; IGFR2
Study 31434737 — Predictive Biomarker (PRD): FCGR2B mRNA
Genes: FCGR2B; CD32; FCG2; IGFR2
Study 21280081 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 24709499 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24709499 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24709499 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 15642068 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 12360165 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18386721 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 2567570 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 795564 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 22112293 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 10589810 — Surrogate Endpoint (SUR): Probing pocket depth
Study 23701746 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 15206062 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15206062 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 7802176 — Surrogate Endpoint (SUR): Blood pressure
Study 4571186 — Surrogate Endpoint (SUR): Blood pressure
Study 19484680 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 23496988 — Surrogate Endpoint (SUR): Blood pressure
Study 17384437 — Surrogate Endpoint (SUR): Serum sodium
Study 15282005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10972580 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 1569442 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 1569442 — Predictive Biomarker (PRD): Hormone receptor
Study 22074419 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study 22074419 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 22074419 — Predictive Biomarker (PRD): ALAD mRNA
Genes: ALAD
Study 29864432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 14624170 — Surrogate Endpoint (SUR): Blood pressure
Study 10072024 — Surrogate Endpoint (SUR): Blood pressure
Study 8575576 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31199778 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 20015100 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 16303845 — Surrogate Endpoint (SUR): Blood pressure
Study 15518626 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 111472 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 31294917 — Surrogate Endpoint (SUR): Blood pressure
Study 25861158 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 21318594 — Surrogate Endpoint (SUR): Blood pressure
Study 22956195 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 12953125 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 1419816 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 26036987 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 21069380 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 11703224 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 11703224 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11703224 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 29701040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29701040 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 27396518 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27396518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23902882 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 9331910 — Predictive Biomarker (PRD): SLC10A3 mRNA
Genes: SLC10A3; DXS253E; P3
Study 25038794 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 27529612 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22480803 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 20479938 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 6250146 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 23660319 — Safety Biomarker (SAF): MTHFR
Study 23660319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 2832102 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 2832102 — Surrogate Endpoint (SUR): Blood pressure
Study 28994661 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28994661 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 28994661 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 28994661 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 28994661 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 17885292 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15531667 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 26522742 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 10467215 — Surrogate Endpoint (SUR): Blood pressure
Study 7762265 — Predictive Biomarker (PRD): DPT mRNA
Genes: DPT
Study 30917258 — Predictive Biomarker (PRD): Hormone receptor
Study 30917258 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 15145965 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 9588639 — Surrogate Endpoint (SUR): Blood pressure
Study 9588639 — Surrogate Endpoint (SUR): Serum sodium
Study 29724155 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 29724155 — Surrogate Endpoint (SUR): Serum testosterone
Study 28363001 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 21670699 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 21670699 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 17374663 — Surrogate Endpoint (SUR): Blood pressure
Study 17374663 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17374663 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 17374663 — Safety Biomarker (SAF): Urinary microalbumin
Study 3295362 — Surrogate Endpoint (SUR): Blood pressure
Study 20679179 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 20679179 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 20679179 — Surrogate Endpoint (SUR): Blood pressure
Study 17217690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 14674497 — Predictive Biomarker (PRD): TPH1 mRNA
Genes: TPH1; TPH; TPRH; TRPH
Study 15553310 — Surrogate Endpoint (SUR): Blood pressure
Study 18673555 — Predictive Biomarker (PRD): EPHA1 mRNA
Genes: EPHA1; EPH; EPHT; EPHT1
Study 26842203 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26842203 — Predictive Biomarker (PRD): Hormone receptor
Study 16278521 — Surrogate Endpoint (SUR): Blood pressure
Study 12403667 — Predictive Biomarker (PRD): NE
Study 10442509 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 28762896 — Surrogate Endpoint (SUR): Blood pressure
Study 25224993 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 25224993 — Surrogate Endpoint (SUR): Blood pressure
Study 1945288 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study 21890776 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10925934 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 10925934 — Surrogate Endpoint (SUR): Blood pressure
Study 29653812 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 29653812 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29653812 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 18281099 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 25217875 — Predictive Biomarker (PRD): TYMS
Genes: Tsase; TMS; HsT422
Study 20236598 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 20236598 — Surrogate Endpoint (SUR): Forced vital capacity
Study 11876837 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 3891346 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 10155359 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10155359 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10155359 — Safety Biomarker (SAF): Interleukin 1
Study 30874471 — Surrogate Endpoint (SUR): Blood pressure
Study 25845088 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25845088 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22404061 — Predictive Biomarker (PRD): SH2D1A mRNA
Genes: SH2D1A; DSHP; SAP
Study 20216298 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20216298 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 20216298 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31553234 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 30249825 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study 17336417 — Safety Biomarker (SAF): Hyaluronic acid
Study 17336417 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 16341296 — Predictive Biomarker (PRD): CAST mRNA
Genes: CAST
Study 12015902 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12015902 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 9562580 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 7947528 — Surrogate Endpoint (SUR): Bone mineral density
Study 3371393 — Surrogate Endpoint (SUR): Blood pressure
Study 22373943 — Predictive Biomarker (PRD): GALR1 mRNA
Genes: GALR1; GALNR; GALNR1
Study 18235409 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 18235409 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 9457906 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 232026 — Surrogate Endpoint (SUR): Blood pressure
Study 28240622 — Surrogate Endpoint (SUR): Blood pressure
Study 15577140 — Surrogate Endpoint (SUR): Bone mineral density
Study 15577140 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 30799375 — Predictive Biomarker (PRD): PIR mRNA
Genes: PIR
Study 30799375 — Predictive Biomarker (PRD): MB mRNA
Genes: MB